bremelanotide and sold under the brand name Vyleesi, is a synthetic peptide used to treat hypoactive sexual desire disorder (HSDD)in premenopausal women. It works by activating melanocortin receptors in the central nervous system to enhance sexual desire and arousal, rather than targeting the vascular system like traditional erectile dysfunction (ED) medications.